GlassScriptPhysician profile
Kulin N Oza
NPI 1427033547
$1,505.59
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $324 · 2023: $710 · 2024: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052 · Education: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.94 |
| Education | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $535.18 | 2021-2024 | Grafix Pl, Oasis, Renasys Touch |
| Organogenesis INC. | $356.85 | 2022-2024 | Puraply, Affinity |
| Bioventus LLC | $159.71 | 2022-2023 | Sonicone Clinic |
| Kerecis Limited | $87.92 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Reprise Biomedical, INC. | $72.53 | 2024 | Miro3d |
| Reddress USA, INC. | $59.90 | 2024 | |
| Tactile Systems Technology INC | $47.03 | 2023 | Flexitouch Plus, Entre Plus |
| Mimedx Group, INC. | $41.09 | 2024 | |
| Integra Lifesciences Corporation | $39.90 | 2023 | Tcc-Ez |
| Molnlycke Health Care US, LLC | $31.14 | 2024 | Mepilex Border Sacrum, Mepitel One, Mepilex Border Flex |
| Kci USA, INC. | $29.69 | 2022 | |
| Convatec INC. | $25.77 | 2023 | |
| Hartmann USA, INC. | $18.88 | 2023 | Zetuvit Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kulin Oza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.